Tuesday, June 2, 2020 NIAID Now: In Pursuit of HIV Cure, NIAID Scientists Update Treatment Interruption Data for Modern ART In a new study, NIAID researchers found that short-term interruption of HIV treatment with modern antiretroviral therapy (ART) regimens results in similar outcomes compared to historical "analytical treatment interruption" data from participants treated with older ART regimens. Their findings, published in the Journal of Infectious Diseases, will support future HIV cure studies by updating the control group data to which experimental outcomes are compared. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107